Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing organization, plans to partner with pharmaceutical companies to provide formulation technology to support the development and manufacturing of fixed-dose combination (FDC) drugs.

FDC drugs combine multiple active pharmaceutical ingredients into a single-dose product, according to Halo Pharma.

Examples of Halo’s formulation capabilities include hot-melt extrusion, wet granulation/roller compaction, extrusion-spheronization, fluid-bed technology, multiparticulate capsule filling, and bilayer press capabilities. Halo also offers polymer-coating options to enable controlled release of different drug substances into one tablet as well as taste-masking methods that use ion-exchange technology.

Source: Halo Pharma